BioMed’s 600K SF Kendall Square Development Leased to Takeda
Massachusetts’ largest life science employer will occupy BioMed Realty’s new 600,000-square-foot lab tower at 585 Third St. in Kendall Square upon completion in 2026.
Hot Property: 585 Kendall
BioMed Realty has received special permit approval from the Cambridge Planning Board for 585 Kendall, a 500,000-square-foot office-lab building including community and performing arts space.
BioMed Picks Arts Partner for Kendall Square Development
A Cambridge-based nonprofit will lead the programming of performance and arts space at a new office-lab building proposed by BioMed Realty in Kendall Square.
Behind BioMed’s Buying Spree
Investors in life science developer BioMed Realty’s parent, a Blackstone Real Estate fund, were in no hurry to cash out and take their profits in 2020 as the pandemic was making the biopharma sector more attractive than ever. So the private equity giant gave them a new, multi-billion-dollar option.
BioMed Unveils Kendall Square Development Plans
BioMed Realty has released its development plans for a long-vacant parcel in one of the nation’s most sought-after commercial real estate markets.
